A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation

08 Jan 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Pancreatic Cancer · Phase 1 · Enrollment 9 · Sponsor: Sun Yat-sen University

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 08 Jan 2026. The item focuses on A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation. Open the detail page to review the full original feed content.